Rakovina unveils oversubscribed financing to accelerate AI drug discovery efforts
Rakovina Therapeutics Inc (TSX-V:RKV) told investors that it has received subscriptions totalling $1.7 million for its previously announced $1.5 million...
Proactive Financial News
2 days ago